Michael Adel

Fidia Farmaceutici SpA

Italian multinational company, with R&D, manufacturing, marketing and sales capabilities, and an extensive product portfolio mainly based on hyaluronic acid (HA) in joint care, skin care, eye care, aesthetic care and regenerative care. Nearly 60 years of R&D have placed Fidia at the forefront in the production of natural and functionalized HA, with different ranges of molecular weight (+1,100 patents). Manufacturing operations – located in Italy - are inspected and approved by major international health authorities, including the US and Korean FDA, the Brazilian ANVISA and G-MED Notified Body, and comply with the strictest international regulations and safety standards. Fidia extends its global reach through local partners in +100 countries worldwide, as well as wholly owned subsidiaries in USA, Germany, Austria, Spain, France, Russia, Czech Republic, Slovakia, Romania, Poland, Egypt and Middle East.